AT
The startup develops radiopharmaceuticals that utilize novel radioactive molecules for targeted imaging and treatment of solid tumors. By enhancing the visualization and therapeutic targeting of aggressive cancers, the company aims to improve diagnostic accuracy and treatment efficacy for oncologists.
Updated 20 months ago
Funding
$6.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops radiopharmaceuticals that utilize novel radioactive molecules for targeted imaging and treatment of solid tumors. By enhancing the visualization and therapeutic targeting of aggressive cancers, the company aims to improve diagnostic accuracy and treatment efficacy for oncologists.